HOME >> BIOLOGY >> NEWS
Dartmouth professor makes case for ethically universal stem cell lines

HANOVER, NH -- Human embryonic stem cells (hESC), those very young cells that are a biological blank slate, have the potential to become more specialized, contributing to the workings of a wide variety of organs and tissues. Their potential to treat diseases such as Parkinsons is slow to be realized because of the ongoing ethical debate over harvesting hESCs, a process called deriving hESC lines. Additionally, its a politically charged issue in the U.S. because it involves federal funding for research.

A recently published paper by Dartmouth Professor Ronald M. Green examines the moral questions and the scientific feasibility of deriving hESC lines in ways that avoid destroying living human embryos. The paper, published in the June 2007 issue of Nature Reviews Genetics, considers six current approaches: altered nuclear transfer, parthenogenesis, single-blastomere biopsy, somatic-cell dedifferentiation, the use of dead embryos, and the use of abnormal embryos. Greens goal, as stated in the paper, is to greatly accelerate hESC research that is closer to being universally acceptable.

I think we can pursue hESC research and also respect the sensitivities of our fellow citizens. Its not impossible to do both, says Green, the Eunice and Julian Cohen Professor for the Study of Ethics and Human Values, and the faculty director of the Dartmouth Ethics Institute. In addition to resolving current debates, he argues, these alternatives can make possible hESC lines that are ethically universal. These would be analogous to the universal O-type blood group: lines that could be used by anyone regardless of their ethical views on the moral status of the embryo.

Green, who is also an adjunct professor of community and family medicine at the Dartmouth Medical School, says, The six approaches differ in technique, most directly in how the blastocyst is created. The blastocyst, where hESCs are found, is the three- to five-day-old embryo that has not yet
'"/>

Contact: Sue Knapp
sue.knapp@dartmouth.edu
603-646-3661
Dartmouth College
7-Jun-2007


Page: 1 2

Related biology news :

1. Plants that produce more vitamin C may result from UCLA-Dartmouth discovery
2. Vitamin extends life in yeast, Dartmouth Medical School researchers find
3. Dartmouth researchers find that arsenic triggers unique mechanism in rare leukemia
4. Dartmouth researchers find that low doses of arsenic have broad impact on hormone activity
5. Dartmouth researchers identify a gene that enhances muscle performance
6. Dartmouth study contributes to research addressing malnutrition and iron deficiency
7. Genetic variation impacts aspirins effectiveness in preventing colon cancer, Dartmouth study finds
8. Dartmouth researchers find a neural signature of bilingualism
9. Dartmouth and GlycoFi report full humanization of therapeutic proteins from yeast
10. GlycoFi and Dartmouth report full humanization of yeast glycosylation pathway in Science
11. Dartmouth researchers find key player in immune system regulation

Post Your Comments:
(Date:8/3/2015)... Synaptics, Inc. (Nasdaq: SYNA ), the ... members of the executive management team will present to ... Leadership Forum on Tuesday, August 11, 2015 at 1:00 ... the Sonnenalp Resort in Vail, CO. ... information. An audio webcast of the event will be ...
(Date:7/31/2015)... de julio de 2015 BGI llevará a cabo ... del 22 al 25 de octubre de 2015, en ... conferencia celebra su décimo aniversario este año. Desde su ... de las reuniones anuales más influyentes del mundo en ... las conferencias científicas más dinámicas, entusiastas y amenas. ...
(Date:7/31/2015)... juillet 2015 La 10e Conférence internationale ... organisée par le BGI du 22 au 25 ... en Chine. La conférence célèbre son ... 2006, l,ICG est devenue l,une des réunions annuelles ... « omiques » et c,est aussi la plus dynamique, la ...
Breaking Biology News(10 mins):La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3
(Date:9/2/2015)...  Neurotech Pharmaceuticals, Inc., announced today the first ... 2 clinical trial of NT-503 Encapsulated Cell Therapy ... choroidal neovascularization secondary to age related macular degeneration ... growth factor (VEGF) receptor protein continuously produced by ... proof-of-concept study will evaluate NT-503 ECT as a ...
(Date:9/2/2015)... 2, 2015 BioLight Life ... the "Company"), a firm that invests in, manages ... diagnostics, announced today that presentations highlighting its IOPtiMate™ ... delivered at the Ophthalmology Futures European Forum and ... Cataract & Refractive Surgeons ("ESCRS"), both taking place ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... will be attending Pharma Ed Resources upcoming educational seminar and training session ... leading speakers, this timely conference will provide Updates & Case Studies on the ...
(Date:9/1/2015)... Swecure, ein Biotechnologieunternehmen, ... Entwicklung neuartiger Therapien für Störungen des Immunsystems ... konzentriert, erhält vom US Patent and Trademark ... patentiert wird. Das Medikament basiert auf einem ... und Entzündungen vorbeugt.   Das Medikament, ...
Breaking Biology Technology:Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 2Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 3Whitehouse Laboratories to Participate in Pharm Ed Resources Extractables, Leachables, & Elemental Impurities Educational Seminar 2Whitehouse Laboratories to Participate in Pharm Ed Resources Extractables, Leachables, & Elemental Impurities Educational Seminar 3Das Patent von Swecure zur Verhinderung von Allergien bei Kindern wird in den USA zugelassen 2
Cached News: